دورية أكاديمية

Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial.

التفاصيل البيبلوغرافية
العنوان: Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial.
المؤلفون: Abdel-Hamid S; Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt. soher.abdel-hamid@med.svu.edu.eg., Ibrahim HM; Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt., Hameed AM; Dermatology, Venereology, and Leprosy Hospital, Qena, Egypt., Hegazy EM; Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt.
المصدر: Archives of dermatological research [Arch Dermatol Res] 2024 Jun 15; Vol. 316 (7), pp. 399. Date of Electronic Publication: 2024 Jun 15.
نوع المنشور: Journal Article; Randomized Controlled Trial
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer Verlag
مواضيع طبية MeSH: Vitiligo*/therapy , Vitiligo*/radiotherapy , Vitiligo*/diagnosis , Platelet-Rich Plasma* , Lasers, Solid-State*/therapeutic use , Skin Pigmentation*/radiation effects , Needles*, Humans ; Female ; Male ; Adult ; Treatment Outcome ; Young Adult ; Middle Aged ; Adolescent ; Dry Needling/methods ; Dry Needling/instrumentation ; Combined Modality Therapy/methods ; Percutaneous Collagen Induction
مستخلص: Vitiligo is considered an autoimmune disease, and its treatment is challenging. We assessed and compared the effect of fractional erbium:yttrium-aluminum-garnet (Er:YAG) laser-assisted delivery of platelet-rich plasma versus microneedling (Mn) with platelet-rich plasma (PRP) in enhancing skin repigmentation in localized stable vitiligo patients. In total, 40 patients with localized stable vitiligo were selected in a random manner into two similar groups (20 each). Group (A) was subjected to fractional Er:YAG laser combined with platelet-rich plasma and Group (B) was subjected to microneedling combined with platelet-rich plasma. The procedure was repeated every 2 weeks for up to 6 months. Each individual was assessed clinically utilizing Vitiligo Area Scoring Index (VASI). Fractional Er:YAG + PRP group achieved better pigmentation100% (excellent 30%, very good 15%, good 30% and satisfactory 25%) which is comparable to Mn + PRP where 80% of cases demonstrate repigmentation (20% very good, 10% good and 50% mild). When comparing the VASI scores for both groups after therapy to the baseline VASI, there was a statistically significant decrease [p = 0.001 for group(A) and 0.003 for group(B)]. Regarding the treatment side effects, there was significantly (p = 0.048) side effects among cases treated with microneedling group(B) (25%) than those fractional Er:Yag laser therapy group(A) (5%). Both forms of therapy demonstrated induction of repigmentation of vitiligo, but fractional Er:YAG laser efficacy is greater when combined with platelet-rich plasma.Clinical trials.gov identifier: NCT05511493.
(© 2024. The Author(s).)
References: Clin Cosmet Investig Dermatol. 2018 Nov 08;11:551-559. (PMID: 30510437)
J Clin Aesthet Dermatol. 2020 Aug;13(8):28-35. (PMID: 33178379)
Genetics. 2006 Nov;174(3):1695-7. (PMID: 16702429)
J Cosmet Dermatol. 2020 Jun;19(6):1473-1478. (PMID: 31524967)
J Cosmet Dermatol. 2020 Apr;19(4):855-862. (PMID: 32030880)
J Cutan Aesthet Surg. 2023 Jul-Sep;16(3):186-191. (PMID: 38189059)
Dermatol Ther. 2021 Nov;34(6):e15159. (PMID: 34657363)
Behav Res Methods. 2007 May;39(2):175-91. (PMID: 17695343)
J Cosmet Dermatol. 2018 Oct;17(5):744-751. (PMID: 29532621)
J Cosmet Dermatol. 2024 Jun;23(6):2220-2230. (PMID: 38470079)
Photobiomodul Photomed Laser Surg. 2021 Sep;39(9):600-606. (PMID: 34546107)
Science. 1908 Jul 10;28(706):49-50. (PMID: 17779291)
Skin Health Dis. 2023 Dec 18;4(1):e317. (PMID: 38312261)
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:3442-5. (PMID: 18002737)
Br J Dermatol. 2016 May;174(5):962-9. (PMID: 26686510)
Lasers Surg Med. 2014 Aug;46(6):443-8. (PMID: 24889492)
J Cosmet Dermatol. 2018 Jun;17(3):365-372. (PMID: 28834191)
Lasers Surg Med. 2020 Jan;52(1):61-69. (PMID: 31254291)
Ann Dermatol. 2011 Nov;23(4):424-31. (PMID: 22148008)
An Bras Dermatol. 2022 Jul-Aug;97(4):478-490. (PMID: 35643735)
J Cosmet Dermatol. 2019 Apr;18(2):581-588. (PMID: 30009490)
J Cosmet Dermatol. 2018 Apr;17(2):165-170. (PMID: 28722334)
Arch Dermatol. 2004 Jun;140(6):677-83. (PMID: 15210457)
فهرسة مساهمة: Keywords: Er–YAG laser; Microneedling; Platelet-rich plasma; VASI score; Vitiligo
سلسلة جزيئية: ClinicalTrials.gov NCT05511493
تواريخ الأحداث: Date Created: 20240615 Date Completed: 20240615 Latest Revision: 20240618
رمز التحديث: 20240618
مُعرف محوري في PubMed: PMC11180153
DOI: 10.1007/s00403-024-03035-8
PMID: 38878236
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-069X
DOI:10.1007/s00403-024-03035-8